Last reviewed · How we verify
NCT03147118
Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis
trial testing Arthrogram in Injection Site in 37 participants. Completed in 15 September 2017.
15 September 2017
Quick facts
| Lead sponsor | Prisma Health-Upstate |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 37 |
| Start date | 1 May 2017 |
| Primary completion | 15 September 2017 |
| Estimated completion | 15 September 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Arthrogram
Conditions studied
- Injection Site — all drugs for Injection Site →
- Arthritis;Hand/Finger(S) — all drugs for Arthritis;Hand/Finger(S) →
Sponsor
Prisma Health-Upstate — full company profile →
Who can join
18 and older, any sex, with Injection Site or Arthritis;Hand/Finger(S). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate the accuracy of trapeziometacarpal injections using palpation alone. The importance of this study is one of education, cost containment, and decreased risk to the patient. If it can be shown that the accuracy of trapeziometacarpal injections using palpation alone is similar to the reported accuracy of ultrasound and fluoroscopy, then these guided techniques may not be needed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03147118
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Injection Site
Currently open trials in the same condition.
- NCT06555523 — Trigger Point Injection in Patients With Myofascial Pain Syndrome · NA · recruiting
- NCT06231719 — Efficacy of Manuel Pressure and Local Cold Spray in Reducing Injection Pain in Pregnant Women · NA · active not recruiting
Other Prisma Health-Upstate trials
Trials by the same sponsor.
- NCT07202039 — Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine · NA · not yet recruiting
- NCT07375212 — VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure · Phase 4 · withdrawn
- NCT07102615 — Intracervical Vasopressin · Phase 4 · recruiting
- NCT07101250 — Preoperative Acetazolamide · Phase 4 · recruiting
- NCT06874413 — Targeted Prehabilitation With Physical Exercise and Inspiratory Muscle Training for Elderly Frail Patients Prior to Vent · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03147118 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prisma Health-Upstate
- Last refreshed: 24 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03147118.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing